Interaction Checker

Changes to website

Wednesday 07 July 2010

We are pleased to announce that the website maintenance has now been completed and we can again update the site.
 
You will notice minor changes to the design and layout of the site, but the majority of the work has been on the infrastructure. However, a couple of more obvious changes have been made:
 
i) Introduction of Quality of Evidence
Quality of Evidence grading has been added to interactions with NNRTIs, NRTIs, raltegravir and maraviroc.  Grades will be added to interactions with protease inhibitors over the next few weeks.  For further information on this new feature, see the New Alert on the home page.
 
ii) New Chart Section on Contraceptives/HRT
Contraceptive steroids have been moved from the Steroid section to a new Contraceptive/HRT section. Progestogens are no longer grouped together, but are listed as individual drugs.
 
SPONSORS
Sponsor logo janssen Sponsor logo gilead Sponsor logo msd Sponsor logo viiv Sponsor logo abbvie Sponsor logo bristol myers squibb
EDITORIAL SPONSORS
Bhiva Glasgow Eacs logo 2014 Basel text